Register Study of the Neoadjuvanten Treatment by Patients With Rectumcarcinoma

NCT03428867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2018-02-13

No results posted yet for this study

Summary

goal of this study is to check the effecivity, feasibility and toxicity of the chemoradiotherapy and hyperthermia

Conditions

  • Feasibilitystudy

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Daniel Zips, Prof.Dr. · University Hospital Tuebingen

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428867 on ClinicalTrials.gov